Handbook of Neuro-Oncology Neuroimaging
portes grátis
Handbook of Neuro-Oncology Neuroimaging
Newton, Herbert B.
Elsevier Science Publishing Co Inc
08/2022
1020
Dura
Inglês
9780128228357
15 a 20 dias
3020
Descrição não disponível.
Section I. Overview of Neuro-Oncological Disorders 1. Overview of Brain Tumor Epidemiology 2. Overview of Pathology and Treatment of Primary Brain Tumors 3. Overview of Pathology and Treatment of Metastatic Brain Tumors 4. Overview of Spinal Cord Tumor Epidemiology 5. Overview of Pathology and Treatment of Primary Spinal Cord Tumors 6. Overview of Pathology and Treatment of Intramedullary Spinal Cord Metastases 7. Epidural Spinal Cord Compression in Adult Neoplasms 8. Leptomeningeal Metastases from Solid Tumors 9. Vascular Disorders: Epidemiology 10. Intracranial Hemorrhage in Cancer Patients 11. Central Nervous System Infarction 12. Intracranial Veno-Occlusive Disease 13. Paraneoplastic Syndromes 14. Neoplastic Plexopathies 15. Neurologic Complications of Oncologic Therapy
Section II. Physics and Basic Science of Neuro-Imaging 16. Physics of Computed Tomography Scanning 17. Physics of Computed Tomography: Contrast Agents 18. Introductory Magnetic Resonance Imaging Physics 19. Advanced Magnetic Resonance Imaging of Brain Tumors 20. Magnetic Resonance Contrast Agents for Neuroradiology 21. Physics of High-Field Magnetic Resonance Imaging and Applications to Brain Tumor Imaging
Section III. Advances in Neuroimaging of Brain Tumors 22. Magnetic Resonance Image Guided Neurosurgery 23. Neurosurgical Treatment Planning 24. Use of Neuroimaging for Radiation Therapy Planning 25. Tumor Treating Fields Therapy Preclinical and Clinical Data 26. Advanced Imaging Techniques and Planning for Laser Interstitial Thermal Therapy 27. Applications of Stereotactic Radiosurgery in Neuro-Oncology 28. Diffusion Magnetic Resonance Imaging in Brain Tumors 29. Imaging and Measuring Diffusion in Brain Tumors 30. Functional Magnetic Resonance Imaging 31. Magnetic Resonance Spectroscopy 32. Perfusion Magnetic Resonance Imaging for Brain Tumor Characterization and Assessment of Treatment Response 33. Positron Emission Tomography and Single-Photon Emission Computed Tomography Physics 34. Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging 35. Methionine PET - Overview and Application to Brain Tumor Imaging and Treatment 36. Ultra-High Field Magnetic Resonance Imaging of Brain Tumors 37. Imaging of Brain Tumors in Animal Models of Central Nervous System Cancer 38. Response Assessment in Neuro-Oncology Criteria: Overview and Future Directions
Section IV. Neuroimaging of Brain Tumors 39. Imaging of Malignant Astrocytomas 40. Low-Grade Astrocytomas 41. Imaging of Oligodendrogliomas 42. Primary Central Nervous System Lymphoma 43. Imaging of CNS Ependymomas 44. Pituitary and Sellar Region Lesions 45. Neoplasms of the Cranial Nerves 46. Meningeal tumors 47. Intracranial Schwannomas 48. Diencephalic and other deep brain tumors 49. Neuro-imaging of Glioneuronal Tumors 50. Pineal region tumors 51. Chordomas and other skull base tumors 52. Pediatric brain tumors 53. Papillary Glioneuronal Tumors 54. Intracranial Metastases 55. Non-Neoplastic mass lesions of the central nervous system 56. Neuroimaging Issues in Assessing Glioma Response to Brain Tumor Therapy 57. Pseudo-progression in Neuro-Oncology: Overview, Pathophysiology and Interpretation 58. Pitfalls in the Neuro-imaging of Brain Tumors
Section V. Neuro-imaging of Other Neuro-Oncological Syndromes 59. Neuroradiology of Leptomeningeal Metastases 60. Imaging of Epidural Spinal Cord Compression 61. Neuroimaging for Surgical Treatment Planning of Neoplastic Disease of the Spine 62. Imaging of Plexopathy in Oncologic Patients 63. Imaging of Peripheral Neurogenic Tumors 64. Neuroimaging of Cerebrovascular Complications in Cancer Patients 65. Neuroimaging in Paraneoplastic Syndromes
Section II. Physics and Basic Science of Neuro-Imaging 16. Physics of Computed Tomography Scanning 17. Physics of Computed Tomography: Contrast Agents 18. Introductory Magnetic Resonance Imaging Physics 19. Advanced Magnetic Resonance Imaging of Brain Tumors 20. Magnetic Resonance Contrast Agents for Neuroradiology 21. Physics of High-Field Magnetic Resonance Imaging and Applications to Brain Tumor Imaging
Section III. Advances in Neuroimaging of Brain Tumors 22. Magnetic Resonance Image Guided Neurosurgery 23. Neurosurgical Treatment Planning 24. Use of Neuroimaging for Radiation Therapy Planning 25. Tumor Treating Fields Therapy Preclinical and Clinical Data 26. Advanced Imaging Techniques and Planning for Laser Interstitial Thermal Therapy 27. Applications of Stereotactic Radiosurgery in Neuro-Oncology 28. Diffusion Magnetic Resonance Imaging in Brain Tumors 29. Imaging and Measuring Diffusion in Brain Tumors 30. Functional Magnetic Resonance Imaging 31. Magnetic Resonance Spectroscopy 32. Perfusion Magnetic Resonance Imaging for Brain Tumor Characterization and Assessment of Treatment Response 33. Positron Emission Tomography and Single-Photon Emission Computed Tomography Physics 34. Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging 35. Methionine PET - Overview and Application to Brain Tumor Imaging and Treatment 36. Ultra-High Field Magnetic Resonance Imaging of Brain Tumors 37. Imaging of Brain Tumors in Animal Models of Central Nervous System Cancer 38. Response Assessment in Neuro-Oncology Criteria: Overview and Future Directions
Section IV. Neuroimaging of Brain Tumors 39. Imaging of Malignant Astrocytomas 40. Low-Grade Astrocytomas 41. Imaging of Oligodendrogliomas 42. Primary Central Nervous System Lymphoma 43. Imaging of CNS Ependymomas 44. Pituitary and Sellar Region Lesions 45. Neoplasms of the Cranial Nerves 46. Meningeal tumors 47. Intracranial Schwannomas 48. Diencephalic and other deep brain tumors 49. Neuro-imaging of Glioneuronal Tumors 50. Pineal region tumors 51. Chordomas and other skull base tumors 52. Pediatric brain tumors 53. Papillary Glioneuronal Tumors 54. Intracranial Metastases 55. Non-Neoplastic mass lesions of the central nervous system 56. Neuroimaging Issues in Assessing Glioma Response to Brain Tumor Therapy 57. Pseudo-progression in Neuro-Oncology: Overview, Pathophysiology and Interpretation 58. Pitfalls in the Neuro-imaging of Brain Tumors
Section V. Neuro-imaging of Other Neuro-Oncological Syndromes 59. Neuroradiology of Leptomeningeal Metastases 60. Imaging of Epidural Spinal Cord Compression 61. Neuroimaging for Surgical Treatment Planning of Neoplastic Disease of the Spine 62. Imaging of Plexopathy in Oncologic Patients 63. Imaging of Peripheral Neurogenic Tumors 64. Neuroimaging of Cerebrovascular Complications in Cancer Patients 65. Neuroimaging in Paraneoplastic Syndromes
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
1H-Mrs; Ablation; Abscess; Acoustic neuroma; Acoustic neuromas; Acute ischemic stroke; ADC; Allergic reactions; Amide proton transfer; Anaplastic astrocytoma (AA)Diffusion; Angiogenesis; Angiography; Anisotropy; Arachnoid cyst; -asparaginase; Astrocytoma; Attenuation correction; Autoimmunity; Back pain; Benign intracranial neoplasm; Benign; Bevacizumab; Bi-exponential; Biologic cancer therapies; Bioluminescence; Blood flow; Blood oxygen level dependent functional MRI (BOLD fMRI)Direct cortical stimulation (DCS)Language functional MRI; Bone scan; Brachial plexus; Brain metastasis; Brain tumor; Brain tumors; Brain tumour; Brain tumours; Brain; b-value; Cancer; CBF; CBV; Central nervous system (CNS) infarction; Central nervous system; Cerebral metastases; Cerebral venous thrombosis; Cerebrospinal fluid (CSF)Cytology; Cerebrovascular disorders; Chemical shift imaging; Chemotherapy; Cholesteatoma; Chondrosarcoma; Chordoma; Circumscribed; Coagulopathy; Cognitive impairment; Compression; Computed tomography; Contrast media; Contrast-enhanced CT; Cortical mapping; Cranial nerve tumours; Cranial nerve; CT scan; CT; CyberKnife; Cystic; DCE-MRI; Demyelinating encephalitis; Dermoid; Desmoplastic infantile astrocytoma (DIA)Desmoplastic infantile ganglioglioma (DIG)Diffuse leptomeningeal glioneuronal tumour; DIC; Diencephalic tumours; Diffusion tensor imaging; Diffusion; Diffusion-weighted imaging; Disorder; DSC-MRI; DTI; Dysembroplastic neuroepithelial tumour; Electric field distribution; Embolisation; En bloc resection; Endpoints; Enhancement; Enhancing; Ependymoma; Epidemiology; Epidermoid; Epidural hematoma; Epidural; Extradural; Filtered back-projection; Fluorodeoxyglucose (FDG)Glioma; fMRI; Gadolinium-based contrast agents (GBCAs)Gadolinium tissue deposition; Gamma knife; Gangliocytoma; Ganglioglioma; Ganglion; Genomics; Germ cell tumour; Glioblastoma multiforme (GBM)Magnetic resonance imaging (MRI)Perfusion; Glioblastoma; Glioma; Gliomas; Glomus; Haemorrhage; Hamartoma; High magnetic field; Hounsfield units; Image reconstruction; Imaging biomarker; Imaging criteria; Imaging studies; Imaging; Immunotherapy; iMRI; Intracranial haemorrhage; Intracranial neoplasm; Intra-CSF; Intradural; Intramedullary; Intraoperative navigation; Intratumoural haemorrhage; Iodine-based contrast agents; iRANO; Iterative reconstruction; IVIM; Juxtasellar; K-space; Ktrans; Kurtosis; l; Laser; Leptomeningeal metastases (LMs)MRI; Leptomeningeal metastases; Leukoencephalopathy; Lhermitte-Duclos; Limbic encephalitis; LINAC; Liponeurocytoma; LITT; Low grade; Lumbosacral plexus; Macroadenoma; Magentic resonance imaging; Magentic resonance spectral imaging; Magnetic field gradient; Magnetic resonance imaging (MRI)Methotrexate; Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetic resonance; Magnetoencephalography (MEG)Near infrared spectroscopy (NIRS)Positron emission tomography (PET)Transcranial magnetic spectroscopy (TMS)WADA test; Malignancy; Malignant; MEG; Meningioma and craniopharyngioma; Meningioma; Meningiomas; Metabolic imaging; Metastases; Metastasis; Metastatic; Microadenoma; Mimics; Molecular imaging; Morton; MR imaging; MR perfusion; MR spectroscopy; MR-guided Focus ultrasound; MRI - MRI Physics; MRI; MRS; Multi-detector; Multi-modal imaging; Multi-nodular and vacuolating neuronal tumour; Multi-slice; Myxoid glioneuronal tumour; Neoplasm; Neoplastic plexopathy; Neoplastic; Nephrogenic systemic fibrosis (NSF)Ultrasmallsuperparamagnetic iron oxide particles (USPIOs)Nephrotoxicity; Neural sheath tumour; neuraxis MRI; Neurocytoma; Neurofibroma; Neurofibromatosis type 2Schwannoma; Neurogenic; Neurography; Neuroimaging; Neurologic; Neurological complications; Neuroma; Neuronal tumours; Neuronavigation; NMDA encephalitis; Non-infiltrative; Nuclear medicine; Occult malignancy; Operative planning; Optic pathway gliomas; Optune; Paediatric; Pancoast syndrome; Papillary glioneuronal tumour; Papillary tumour of the pineal region; Paraganglioma
Section I. Overview of Neuro-Oncological Disorders 1. Overview of Brain Tumor Epidemiology 2. Overview of Pathology and Treatment of Primary Brain Tumors 3. Overview of Pathology and Treatment of Metastatic Brain Tumors 4. Overview of Spinal Cord Tumor Epidemiology 5. Overview of Pathology and Treatment of Primary Spinal Cord Tumors 6. Overview of Pathology and Treatment of Intramedullary Spinal Cord Metastases 7. Epidural Spinal Cord Compression in Adult Neoplasms 8. Leptomeningeal Metastases from Solid Tumors 9. Vascular Disorders: Epidemiology 10. Intracranial Hemorrhage in Cancer Patients 11. Central Nervous System Infarction 12. Intracranial Veno-Occlusive Disease 13. Paraneoplastic Syndromes 14. Neoplastic Plexopathies 15. Neurologic Complications of Oncologic Therapy
Section II. Physics and Basic Science of Neuro-Imaging 16. Physics of Computed Tomography Scanning 17. Physics of Computed Tomography: Contrast Agents 18. Introductory Magnetic Resonance Imaging Physics 19. Advanced Magnetic Resonance Imaging of Brain Tumors 20. Magnetic Resonance Contrast Agents for Neuroradiology 21. Physics of High-Field Magnetic Resonance Imaging and Applications to Brain Tumor Imaging
Section III. Advances in Neuroimaging of Brain Tumors 22. Magnetic Resonance Image Guided Neurosurgery 23. Neurosurgical Treatment Planning 24. Use of Neuroimaging for Radiation Therapy Planning 25. Tumor Treating Fields Therapy Preclinical and Clinical Data 26. Advanced Imaging Techniques and Planning for Laser Interstitial Thermal Therapy 27. Applications of Stereotactic Radiosurgery in Neuro-Oncology 28. Diffusion Magnetic Resonance Imaging in Brain Tumors 29. Imaging and Measuring Diffusion in Brain Tumors 30. Functional Magnetic Resonance Imaging 31. Magnetic Resonance Spectroscopy 32. Perfusion Magnetic Resonance Imaging for Brain Tumor Characterization and Assessment of Treatment Response 33. Positron Emission Tomography and Single-Photon Emission Computed Tomography Physics 34. Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging 35. Methionine PET - Overview and Application to Brain Tumor Imaging and Treatment 36. Ultra-High Field Magnetic Resonance Imaging of Brain Tumors 37. Imaging of Brain Tumors in Animal Models of Central Nervous System Cancer 38. Response Assessment in Neuro-Oncology Criteria: Overview and Future Directions
Section IV. Neuroimaging of Brain Tumors 39. Imaging of Malignant Astrocytomas 40. Low-Grade Astrocytomas 41. Imaging of Oligodendrogliomas 42. Primary Central Nervous System Lymphoma 43. Imaging of CNS Ependymomas 44. Pituitary and Sellar Region Lesions 45. Neoplasms of the Cranial Nerves 46. Meningeal tumors 47. Intracranial Schwannomas 48. Diencephalic and other deep brain tumors 49. Neuro-imaging of Glioneuronal Tumors 50. Pineal region tumors 51. Chordomas and other skull base tumors 52. Pediatric brain tumors 53. Papillary Glioneuronal Tumors 54. Intracranial Metastases 55. Non-Neoplastic mass lesions of the central nervous system 56. Neuroimaging Issues in Assessing Glioma Response to Brain Tumor Therapy 57. Pseudo-progression in Neuro-Oncology: Overview, Pathophysiology and Interpretation 58. Pitfalls in the Neuro-imaging of Brain Tumors
Section V. Neuro-imaging of Other Neuro-Oncological Syndromes 59. Neuroradiology of Leptomeningeal Metastases 60. Imaging of Epidural Spinal Cord Compression 61. Neuroimaging for Surgical Treatment Planning of Neoplastic Disease of the Spine 62. Imaging of Plexopathy in Oncologic Patients 63. Imaging of Peripheral Neurogenic Tumors 64. Neuroimaging of Cerebrovascular Complications in Cancer Patients 65. Neuroimaging in Paraneoplastic Syndromes
Section II. Physics and Basic Science of Neuro-Imaging 16. Physics of Computed Tomography Scanning 17. Physics of Computed Tomography: Contrast Agents 18. Introductory Magnetic Resonance Imaging Physics 19. Advanced Magnetic Resonance Imaging of Brain Tumors 20. Magnetic Resonance Contrast Agents for Neuroradiology 21. Physics of High-Field Magnetic Resonance Imaging and Applications to Brain Tumor Imaging
Section III. Advances in Neuroimaging of Brain Tumors 22. Magnetic Resonance Image Guided Neurosurgery 23. Neurosurgical Treatment Planning 24. Use of Neuroimaging for Radiation Therapy Planning 25. Tumor Treating Fields Therapy Preclinical and Clinical Data 26. Advanced Imaging Techniques and Planning for Laser Interstitial Thermal Therapy 27. Applications of Stereotactic Radiosurgery in Neuro-Oncology 28. Diffusion Magnetic Resonance Imaging in Brain Tumors 29. Imaging and Measuring Diffusion in Brain Tumors 30. Functional Magnetic Resonance Imaging 31. Magnetic Resonance Spectroscopy 32. Perfusion Magnetic Resonance Imaging for Brain Tumor Characterization and Assessment of Treatment Response 33. Positron Emission Tomography and Single-Photon Emission Computed Tomography Physics 34. Positron Emission Tomography and Single Photon Emission Computed Tomography Imaging 35. Methionine PET - Overview and Application to Brain Tumor Imaging and Treatment 36. Ultra-High Field Magnetic Resonance Imaging of Brain Tumors 37. Imaging of Brain Tumors in Animal Models of Central Nervous System Cancer 38. Response Assessment in Neuro-Oncology Criteria: Overview and Future Directions
Section IV. Neuroimaging of Brain Tumors 39. Imaging of Malignant Astrocytomas 40. Low-Grade Astrocytomas 41. Imaging of Oligodendrogliomas 42. Primary Central Nervous System Lymphoma 43. Imaging of CNS Ependymomas 44. Pituitary and Sellar Region Lesions 45. Neoplasms of the Cranial Nerves 46. Meningeal tumors 47. Intracranial Schwannomas 48. Diencephalic and other deep brain tumors 49. Neuro-imaging of Glioneuronal Tumors 50. Pineal region tumors 51. Chordomas and other skull base tumors 52. Pediatric brain tumors 53. Papillary Glioneuronal Tumors 54. Intracranial Metastases 55. Non-Neoplastic mass lesions of the central nervous system 56. Neuroimaging Issues in Assessing Glioma Response to Brain Tumor Therapy 57. Pseudo-progression in Neuro-Oncology: Overview, Pathophysiology and Interpretation 58. Pitfalls in the Neuro-imaging of Brain Tumors
Section V. Neuro-imaging of Other Neuro-Oncological Syndromes 59. Neuroradiology of Leptomeningeal Metastases 60. Imaging of Epidural Spinal Cord Compression 61. Neuroimaging for Surgical Treatment Planning of Neoplastic Disease of the Spine 62. Imaging of Plexopathy in Oncologic Patients 63. Imaging of Peripheral Neurogenic Tumors 64. Neuroimaging of Cerebrovascular Complications in Cancer Patients 65. Neuroimaging in Paraneoplastic Syndromes
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
1H-Mrs; Ablation; Abscess; Acoustic neuroma; Acoustic neuromas; Acute ischemic stroke; ADC; Allergic reactions; Amide proton transfer; Anaplastic astrocytoma (AA)Diffusion; Angiogenesis; Angiography; Anisotropy; Arachnoid cyst; -asparaginase; Astrocytoma; Attenuation correction; Autoimmunity; Back pain; Benign intracranial neoplasm; Benign; Bevacizumab; Bi-exponential; Biologic cancer therapies; Bioluminescence; Blood flow; Blood oxygen level dependent functional MRI (BOLD fMRI)Direct cortical stimulation (DCS)Language functional MRI; Bone scan; Brachial plexus; Brain metastasis; Brain tumor; Brain tumors; Brain tumour; Brain tumours; Brain; b-value; Cancer; CBF; CBV; Central nervous system (CNS) infarction; Central nervous system; Cerebral metastases; Cerebral venous thrombosis; Cerebrospinal fluid (CSF)Cytology; Cerebrovascular disorders; Chemical shift imaging; Chemotherapy; Cholesteatoma; Chondrosarcoma; Chordoma; Circumscribed; Coagulopathy; Cognitive impairment; Compression; Computed tomography; Contrast media; Contrast-enhanced CT; Cortical mapping; Cranial nerve tumours; Cranial nerve; CT scan; CT; CyberKnife; Cystic; DCE-MRI; Demyelinating encephalitis; Dermoid; Desmoplastic infantile astrocytoma (DIA)Desmoplastic infantile ganglioglioma (DIG)Diffuse leptomeningeal glioneuronal tumour; DIC; Diencephalic tumours; Diffusion tensor imaging; Diffusion; Diffusion-weighted imaging; Disorder; DSC-MRI; DTI; Dysembroplastic neuroepithelial tumour; Electric field distribution; Embolisation; En bloc resection; Endpoints; Enhancement; Enhancing; Ependymoma; Epidemiology; Epidermoid; Epidural hematoma; Epidural; Extradural; Filtered back-projection; Fluorodeoxyglucose (FDG)Glioma; fMRI; Gadolinium-based contrast agents (GBCAs)Gadolinium tissue deposition; Gamma knife; Gangliocytoma; Ganglioglioma; Ganglion; Genomics; Germ cell tumour; Glioblastoma multiforme (GBM)Magnetic resonance imaging (MRI)Perfusion; Glioblastoma; Glioma; Gliomas; Glomus; Haemorrhage; Hamartoma; High magnetic field; Hounsfield units; Image reconstruction; Imaging biomarker; Imaging criteria; Imaging studies; Imaging; Immunotherapy; iMRI; Intracranial haemorrhage; Intracranial neoplasm; Intra-CSF; Intradural; Intramedullary; Intraoperative navigation; Intratumoural haemorrhage; Iodine-based contrast agents; iRANO; Iterative reconstruction; IVIM; Juxtasellar; K-space; Ktrans; Kurtosis; l; Laser; Leptomeningeal metastases (LMs)MRI; Leptomeningeal metastases; Leukoencephalopathy; Lhermitte-Duclos; Limbic encephalitis; LINAC; Liponeurocytoma; LITT; Low grade; Lumbosacral plexus; Macroadenoma; Magentic resonance imaging; Magentic resonance spectral imaging; Magnetic field gradient; Magnetic resonance imaging (MRI)Methotrexate; Magnetic resonance imaging; Magnetic resonance spectroscopy; Magnetic resonance; Magnetoencephalography (MEG)Near infrared spectroscopy (NIRS)Positron emission tomography (PET)Transcranial magnetic spectroscopy (TMS)WADA test; Malignancy; Malignant; MEG; Meningioma and craniopharyngioma; Meningioma; Meningiomas; Metabolic imaging; Metastases; Metastasis; Metastatic; Microadenoma; Mimics; Molecular imaging; Morton; MR imaging; MR perfusion; MR spectroscopy; MR-guided Focus ultrasound; MRI - MRI Physics; MRI; MRS; Multi-detector; Multi-modal imaging; Multi-nodular and vacuolating neuronal tumour; Multi-slice; Myxoid glioneuronal tumour; Neoplasm; Neoplastic plexopathy; Neoplastic; Nephrogenic systemic fibrosis (NSF)Ultrasmallsuperparamagnetic iron oxide particles (USPIOs)Nephrotoxicity; Neural sheath tumour; neuraxis MRI; Neurocytoma; Neurofibroma; Neurofibromatosis type 2Schwannoma; Neurogenic; Neurography; Neuroimaging; Neurologic; Neurological complications; Neuroma; Neuronal tumours; Neuronavigation; NMDA encephalitis; Non-infiltrative; Nuclear medicine; Occult malignancy; Operative planning; Optic pathway gliomas; Optune; Paediatric; Pancoast syndrome; Papillary glioneuronal tumour; Papillary tumour of the pineal region; Paraganglioma
